chr20:5095599:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr20:5,095,599-5,107,272 |
hg38 | chr20:5,114,953-5,126,626 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.015 | squamous cell carcinoma | Significantly elevated levels of Ki-67, p27, and PCNA in IP with squamous cell c... | BeFree,LHGDN | 25013792 | Detail |
0.002 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
<0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
0.080 | brain ischemia | NA | RGD | Detail | |
0.080 | Transient ischemic attack | NA | RGD | Detail | |
0.004 | Malignant tumor of cervix | Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis... | BeFree | 25120779 | Detail |
0.004 | Malignant tumor of cervix | Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregul... | BeFree | 25921283 | Detail |
<0.001 | Cervix Diseases | NA | BeFree | Detail | |
0.003 | Uterine Cervical Neoplasm | NA | BeFree,LHGDN | Detail | |
0.080 | Chagas Cardiomyopathy | NA | RGD | Detail | |
<0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
<0.001 | cholesteatoma | NA | BeFree | Detail | |
<0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.120 | Colonic Neoplasms | NA | CTD_human | Detail | |
<0.001 | Colonic Polyps | NA | BeFree | Detail | |
0.007 | colorectal carcinoma | NA | BeFree | Detail | |
0.006 | Colorectal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Condylomata Acuminata | NA | BeFree | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Coronary heart disease | NA | BeFree | Detail | |
0.003 | adenoid cystic carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Diabetes | NA | BeFree | Detail | |
<0.001 | diabetes mellitus | NA | BeFree | Detail | |
<0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
<0.001 | encephalitis | NA | BeFree | Detail | |
0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
<0.001 | endometrial hyperplasia | NA | BeFree | Detail | |
0.001 | endometriosis | NA | BeFree | Detail | |
<0.001 | Esophageal Achalasia | NA | BeFree | Detail | |
0.006 | Esophageal Neoplasms | Overexpression of cyclin B has been shown to affect survival in some malignant t... | BeFree,GAD | 25315186 | Detail |
<0.001 | Exanthema | NA | BeFree | Detail | |
<0.001 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
0.002 | glioblastoma | Glioblastoma development is often associated with alteration in the activity and... | BeFree | 25817794 | Detail |
0.120 | IgA glomerulonephritis | NA | BeFree,CTD_human | Detail | |
0.120 | Focal glomerulosclerosis | NA | CTD_human | Detail | |
0.002 | Graft-vs-Host Disease | NA | GAD | Detail | |
<0.001 | granulosa cell tumor | NA | BeFree | Detail | |
<0.001 | Graves Disease | NA | BeFree | Detail | |
0.002 | Head and Neck Neoplasms | NA | GAD | Detail | |
<0.001 | hemangioma | NA | BeFree | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
<0.001 | hepatitis | NA | BeFree | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
<0.001 | hepatitis B | NA | BeFree | Detail | |
<0.001 | hepatitis C | NA | BeFree | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
0.003 | HIV Infections | NA | BeFree | Detail | |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
<0.001 | HTLV-I Infections | NA | BeFree | Detail | |
<0.001 | hyperinsulinism | PCNA staining was increased 3- to 3.5-fold, indicating increased insulin-cell pr... | BeFree | 24941889 | Detail |
<0.001 | hypoglycemia | NA | BeFree | Detail | |
0.080 | hypothyroidism | NA | RGD | Detail | |
0.121 | ischemia | NA | BeFree,CTD_human | Detail | |
0.080 | Jaundice, Obstructive | NA | RGD | Detail | |
<0.001 | keratoacanthoma | NA | BeFree | Detail | |
<0.001 | actinic keratosis | NA | BeFree | Detail | |
<0.001 | Kidney Failure, Acute | The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interact... | BeFree | 26187004 | Detail |
0.002 | Laryngeal neoplasm | NA | GAD | Detail | |
0.091 | Fibroid Tumor | NA | BeFree,LHGDN,RGD | Detail | |
0.003 | leukemia | Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acq... | BeFree | 25596730 | Detail |
0.002 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.002 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
<0.001 | Leukoencephalopathy, Progressive Multifocal | NA | BeFree | Detail | |
<0.001 | Lichen Sclerosus et Atrophicus | NA | BeFree | Detail | |
<0.001 | liver cirrhosis | NA | BeFree | Detail | |
0.002 | Liver neoplasms | Knockout of SRC-1 in mice reduced diethylnitrosamine/CCl4-induced tumor formatio... | BeFree | 26082485 | Detail |
0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
0.124 | Lung Neoplasms | Our results imply that CXCL16-CXCR6 axis is involved in the regulation of viabil... | BeFree,CTD_human,LHGDN | 24897301 | Detail |
<0.001 | Lupus Vulgaris | NA | BeFree | Detail | |
<0.001 | Lupus Erythematosus, Discoid | NA | BeFree | Detail | |
0.001 | Lupus Erythematosus, Systemic | Autoantibodies to proliferating cell nuclear antigen (PCNA) are specifically, if... | BeFree | 24836587 | Detail |
0.006 | lymphoma | NA | BeFree | Detail | |
<0.001 | Lymphoma, Follicular | We observed a significant increase in ΔNp73 expression and ΔNp73:TAp73 ratio, lo... | BeFree | 24660851 | Detail |
0.010 | Malignant neoplasm of stomach | Knockdown of EGFR reduced cell proliferation and invasion of GC with decreased e... | BeFree | 25394504 | Detail |
0.010 | Malignant neoplasm of stomach | Functional analysis studies revealed that ectopic expression of miR-133a reduced... | BeFree | 25620172 | Detail |
0.080 | Mammary Neoplasms, Experimental | NA | RGD | Detail | |
<0.001 | megaesophagus | NA | BeFree | Detail | |
0.017 | melanoma | Using A375 (BRAF-mutated) and Hs294t (non BRAF-mutated but highly metastatic) hu... | BeFree,LHGDN | 25174976 | Detail |
0.017 | melanoma | Cell cycle control is a promising target in the management of melanoma with earl... | BeFree,LHGDN | 25588041 | Detail |
0.002 | Meningeal Neoplasms | NA | GAD | Detail | |
0.003 | meningioma | NA | BeFree,GAD | Detail | |
<0.001 | Microphthalmos | NA | BeFree | Detail | |
<0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
0.002 | Mouth Neoplasms | NA | GAD | Detail | |
0.010 | multiple myeloma | Inhibitors of cyclin-dependent kinases 9 have been developed as potential antica... | BeFree,LHGDN | 24803299 | Detail |
0.002 | multiple sclerosis | NA | GAD | Detail | |
<0.001 | Neck Neoplasms | NA | BeFree | Detail | |
<0.001 | Neonatal hepatitis | NA | BeFree | Detail | |
0.008 | Neoplasm Metastasis | Our results imply that CXCL16-CXCR6 axis is involved in the regulation of viabil... | BeFree | 24897301 | Detail |
0.120 | Neoplasms, Experimental | NA | CTD_human | Detail | |
<0.001 | multiple endocrine neoplasia | NA | BeFree | Detail | |
<0.001 | nephritis | NA | BeFree | Detail | |
<0.001 | nephroblastoma | NA | BeFree | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
0.004 | neuroblastoma | NA | BeFree | Detail | |
0.003 | acoustic neuroma | NA | BeFree,GAD | Detail | |
<0.001 | Melanocytic nevus | NA | BeFree | Detail | |
0.007 | Glioma | The XRCC1 Arg194Trp variant affects the proliferating cell nuclear antigen( PCNA... | BeFree | 25227852 | Detail |
<0.001 | obesity | NA | BeFree | Detail | |
<0.001 | Odontogenic Tumors | NA | BeFree | Detail | |
<0.001 | oligodendroglioma | NA | BeFree | Detail | |
0.080 | osteoporosis | NA | RGD | Detail | |
0.002 | osteosarcoma | Overexpression of RASSF5 markedly suppressed cell proliferation and invasion, an... | BeFree | 25109282 | Detail |
0.002 | osteosarcoma | Inhibition of osteosarcoma cell progression by MacroH2A via the downregulation o... | BeFree | 25378143 | Detail |
0.002 | osteosarcoma | When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was dow... | BeFree | 25530340 | Detail |
0.002 | osteosarcoma | Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and... | BeFree | 26434118 | Detail |
0.006 | ovarian carcinoma | Cell growth was inhibited by the overexpression of miR-138, although not by the ... | BeFree | 25190487 | Detail |
0.006 | ovarian carcinoma | Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and... | BeFree | 26434118 | Detail |
0.008 | Pancreatic Neoplasm | P27(Kip1) expression and cleaved caspase-3 are increased, while cyclin E express... | BeFree,LHGDN | 25677816 | Detail |
<0.001 | Parkinson disease | Our results indicate that the interaction of PCNA and DNA pol-β contributes to n... | BeFree | 25184665 | Detail |
<0.001 | periodontitis | However, susceptibility genes, such as CDKN2BAS (Cyclin Dependend KiNase 2B Anti... | BeFree | 24528298 | Detail |
0.002 | Pharyngeal Neoplasms | NA | GAD | Detail | |
0.001 | pituitary adenoma | NA | BeFree | Detail | |
0.001 | Pituitary Diseases | MEG3, HOTAIR, MALAT-1 and proliferating cell nuclear antigen (PCNA) were detecte... | BeFree | 24469926 | Detail |
0.001 | Pituitary Diseases | Pituitary cyclin E/E2F1 signaling is a previously unappreciated molecular mechan... | BeFree | 25942479 | Detail |
0.003 | Pituitary Neoplasms | NA | LHGDN | Detail | |
<0.001 | placental insufficiency | NA | BeFree | Detail | |
<0.001 | plague | NA | BeFree | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
<0.001 | polycystic ovary syndrome | Our results indicated that the downregulation of CFTR in the cystic follicles wa... | BeFree | 25646509 | Detail |
0.001 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
0.001 | Precancerous Conditions | NA | BeFree | Detail | |
<0.001 | Preleukemia | NA | BeFree | Detail | |
0.003 | prolactinoma | NA | BeFree,LHGDN | Detail | |
0.003 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.120 | psoriasis | NA | BeFree,CTD_human | Detail | |
<0.001 | pterygium | NA | BeFree | Detail | |
<0.001 | Rectal Neoplasms | NA | BeFree | Detail | |
0.014 | retinoblastoma | The data demonstrated that the expression of P21, cyclin D and phosphorylated re... | BeFree | 25338527 | Detail |
0.014 | retinoblastoma | Cyclin-dependent kinase inhibitors (CDKi) target the retinoblastoma (RB) signali... | BeFree | 25557169 | Detail |
<0.001 | Rett syndrome | NA | BeFree | Detail | |
<0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
0.002 | Kaposi sarcoma | NA | BeFree | Detail | |
<0.001 | schistosomiasis | NA | BeFree | Detail | |
<0.001 | Seizures | NA | BeFree | Detail | |
<0.001 | seminoma | NA | BeFree | Detail | |
<0.001 | Shy-Drager Syndrome | NA | BeFree | Detail | |
<0.001 | Skin Neoplasms | NA | BeFree | Detail | |
0.003 | Skin Ulcer | NA | LHGDN | Detail | |
0.003 | Stomach Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | teratoma | NA | BeFree | Detail | |
<0.001 | Testicular Neoplasms | NA | BeFree | Detail | |
<0.001 | Thromboembolism | NA | BeFree | Detail | |
<0.001 | Thyroid Neoplasm | NA | BeFree | Detail | |
<0.001 | Trisomy | NA | BeFree | Detail | |
<0.001 | Chagas disease | NA | BeFree | Detail | |
0.003 | tuberous sclerosis | NA | BeFree,LHGDN | Detail | |
0.003 | Uterine Fibroids | NA | BeFree | Detail | |
<0.001 | Virus Diseases | NA | BeFree | Detail | |
<0.001 | common wart | NA | BeFree | Detail | |
<0.001 | Fibromatosis, Aggressive | NA | BeFree | Detail | |
0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
<0.001 | High Grade Lymphoma (neoplasm) | NA | BeFree | Detail | |
0.001 | diffuse large B-cell lymphoma | NA | BeFree | Detail | |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | Li-Fraumeni syndrome | NA | BeFree | Detail | |
<0.001 | Neurofibrillary degeneration (morphologic abnormality) | NA | BeFree | Detail | |
<0.001 | Polycystic Kidney, Autosomal Dominant | NA | BeFree | Detail | |
<0.001 | autosomal recessive polycystic kidney disease | NA | BeFree | Detail | |
<0.001 | Encephalopathies | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | cataract | NA | BeFree | Detail | |
<0.001 | benign neoplasm | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | In the present study we have mined these two studies for new therapeutic agents ... | BeFree | 25198282 | Detail |
0.080 | sciatic neuropathy | NA | RGD | Detail | |
<0.001 | Thyroid Gland Follicular Adenoma | NA | BeFree | Detail | |
<0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
0.004 | esophageal carcinoma | Overexpression of cyclin B has been shown to affect survival in some malignant t... | BeFree | 25315186 | Detail |
<0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Cleft palate with cleft lip | RA treatment reduced the expression of several of the investigated genes; the pr... | BeFree | 24509616 | Detail |
<0.001 | adrenoleukodystrophy | NA | BeFree | Detail | |
<0.001 | porphyria cutanea tarda | NA | BeFree | Detail | |
0.003 | Cicatrix, Hypertrophic | NA | LHGDN | Detail | |
<0.001 | Russell-Silver syndrome | NA | BeFree | Detail | |
0.003 | Williams syndrome | NA | LHGDN | Detail | |
0.005 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | follicular adenoma | NA | BeFree | Detail | |
<0.001 | Undifferentiated carcinoma | NA | BeFree | Detail | |
0.002 | Germ cell tumor | NA | BeFree | Detail | |
<0.001 | Pneumonia, Interstitial | NA | BeFree | Detail | |
0.003 | Lichen Planus, Oral | NA | LHGDN | Detail | |
<0.001 | adenomyoma | NA | BeFree | Detail | |
0.121 | hepatoblastoma | NA | BeFree,CTD_human | Detail | |
<0.001 | Giant Cell Tumor of Bone | NA | BeFree | Detail | |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma, Clear Cell | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma | NA | BeFree | Detail | |
<0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
0.001 | Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Squamous Cell Neoplasms | NA | BeFree | Detail | |
<0.001 | inverted papilloma | Significantly elevated levels of Ki-67, p27, and PCNA in IP with squamous cell c... | BeFree | 25013792 | Detail |
<0.001 | Nevus, Blue | NA | BeFree | Detail | |
<0.001 | Rhabdoid Tumor | NA | BeFree | Detail | |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Renal Pelvis and Ureter Urothelial Carcinoma | NA | BeFree | Detail | |
<0.001 | pituitary-dependent Cushing's disease | Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target f... | BeFree | 25942479 | Detail |
<0.001 | Lesion of brain | NA | BeFree | Detail | |
<0.001 | Fibrillation | NA | BeFree | Detail | |
<0.001 | Memory impairment | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | In conclusion, the present study reveals that the increased expression of OCT4 i... | BeFree | 25017645 | Detail |
0.002 | pancreatic carcinoma | Consistent with this, CST1 mRNA overexpression was correlated closely with malig... | BeFree | 25577248 | Detail |
<0.001 | Gastrointestinal Stromal Tumors | NA | BeFree | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | islet cell tumor | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of lung | These effects may result from the ability of miR-5100 to promote G1/S transition... | BeFree,GAD | 25754817 | Detail |
<0.001 | Proliferative vitreoretinopathy | Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and ... | BeFree | 25421815 | Detail |
<0.001 | Carcinoma, Lewis Lung | NA | BeFree | Detail | |
<0.001 | Malignant Meningioma | NA | BeFree | Detail | |
<0.001 | Collagen-vascular disease | NA | BeFree | Detail | |
<0.001 | parathyroid adenoma | NA | BeFree | Detail | |
<0.001 | Epithelial hyperplasia of skin | NA | BeFree | Detail | |
<0.001 | Acute respiratory failure | The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interact... | BeFree | 26187004 | Detail |
<0.001 | Liver cyst | NA | BeFree | Detail | |
<0.001 | Xeroderma pigmentosum, group A | NA | BeFree | Detail | |
<0.001 | Renal glomerular disease | NA | BeFree | Detail | |
<0.001 | Simple renal cyst | NA | BeFree | Detail | |
<0.001 | Coinfection | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of colon stage IV | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | gastric adenocarcinoma | COX-2 inhibitor celecoxib also suppressed the proliferative activities of GAC ce... | BeFree | 24992958 | Detail |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | Downregulation of NF-κB, cyclin D1, cyclin E1, matrix metalloproteinases (MMP)-2... | BeFree | 24972653 | Detail |
0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | cervical adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | stage, Kaposi's sarcoma | NA | BeFree | Detail | |
<0.001 | stage, non-small cell lung cancer | NA | BeFree | Detail | |
<0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | benign meningioma | NA | BeFree | Detail | |
0.004 | cervix carcinoma | Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis... | BeFree | 25120779 | Detail |
0.004 | cervix carcinoma | Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregul... | BeFree | 25921283 | Detail |
<0.001 | Restenosis | NA | BeFree | Detail | |
0.080 | Inflammatory disease of mucous membrane | NA | RGD | Detail | |
<0.001 | Triploidy syndrome | NA | BeFree | Detail | |
<0.001 | High-Grade Squamous Intraepithelial Lesions | NA | BeFree | Detail | |
<0.001 | Cellular Blue Nevus | NA | BeFree | Detail | |
<0.001 | Teratoma, Malignant | NA | BeFree | Detail | |
0.002 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
<0.001 | Non-Functioning Pituitary Gland Neoplasm | Furthermore, PCNA mRNA levels markedly increased in invasive NFPAs compared to n... | BeFree | 24469926 | Detail |
<0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
<0.001 | Jaw Keratocyst | NA | BeFree | Detail | |
<0.001 | Chronic liver disease | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | Downregulation of NF-κB, cyclin D1, cyclin E1, matrix metalloproteinases (MMP)-2... | BeFree | 24972653 | Detail |
0.002 | Malignant neoplasm of pancreas | In conclusion, the present study reveals that the increased expression of OCT4 i... | BeFree | 25017645 | Detail |
0.002 | Malignant neoplasm of pancreas | Consistent with this, CST1 mRNA overexpression was correlated closely with malig... | BeFree | 25577248 | Detail |
<0.001 | Anal intraepithelial neoplasia | NA | BeFree | Detail | |
<0.001 | Early gastric cancer | NA | BeFree | Detail | |
<0.001 | gastric lymphoma | NA | BeFree | Detail | |
<0.001 | Atypical endometrial hyperplasia | NA | BeFree | Detail | |
<0.001 | Skin callus | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of prostate | Antitumor effects of a novel small molecule targeting PCNA chromatin association... | BeFree | 25253786 | Detail |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
0.003 | Hematologic Neoplasms | NA | BeFree,GAD | Detail | |
<0.001 | Plasma cell inflammation | NA | BeFree | Detail | |
<0.001 | multiple system atrophy | NA | BeFree | Detail | |
<0.001 | Hereditary gingival fibromatosis | NA | BeFree | Detail | |
<0.001 | lupus erythematosus | NA | BeFree | Detail | |
<0.001 | Hemimegalencephaly | NA | BeFree | Detail | |
0.004 | endometrial carcinoma | Overexpression of cyclin B has been shown to affect survival in some malignant t... | BeFree | 25315186 | Detail |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Benign neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Benign neurologic neoplasms | NA | BeFree | Detail | |
<0.001 | Chronic active hepatitis | NA | BeFree | Detail | |
<0.001 | Buffalo hump | NA | BeFree | Detail | |
0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
<0.001 | Hepatitis B, Chronic | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of esophagus | Overexpression of cyclin B has been shown to affect survival in some malignant t... | BeFree | 25315186 | Detail |
0.001 | Thyroid carcinoma | Doxorubicin (DOX), a broad‑spectrum anthra-cyclin, is in wide clinical use for t... | BeFree | 25592304 | Detail |
<0.001 | Ewings sarcoma | NA | BeFree | Detail | |
<0.001 | Oropharyngeal disorders | NA | BeFree | Detail | |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
0.002 | Osteosarcoma of bone | Overexpression of RASSF5 markedly suppressed cell proliferation and invasion, an... | BeFree | 25109282 | Detail |
0.002 | Osteosarcoma of bone | Inhibition of osteosarcoma cell progression by MacroH2A via the downregulation o... | BeFree | 25378143 | Detail |
0.002 | Osteosarcoma of bone | When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was dow... | BeFree | 25530340 | Detail |
0.002 | Osteosarcoma of bone | Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and... | BeFree | 26434118 | Detail |
<0.001 | Carcinoma of larynx | NA | BeFree | Detail | |
0.023 | Carcinogenesis | Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis. | BeFree | 25267403 | Detail |
0.023 | Carcinogenesis | Genetic alteration of cyclin-dependent kinase inhibitors has been associated wit... | BeFree | 25695279 | Detail |
0.023 | Carcinogenesis | RV-cyclin presents a novel and ancient mechanism of retrovirus-induced oncogenes... | BeFree | 25741012 | Detail |
0.023 | Carcinogenesis | This study was performed to screen cyclin D1 (CCND1) and cyclin dependent kinase... | BeFree | 26416047 | Detail |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Initiation | NA | BeFree | Detail | |
0.007 | prostate carcinoma | Antitumor effects of a novel small molecule targeting PCNA chromatin association... | BeFree | 25253786 | Detail |
<0.001 | CARCINOMA OF VULVA | NA | BeFree | Detail | |
<0.001 | Epithelial ovarian cancer | Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and... | BeFree | 26434118 | Detail |
<0.001 | invasive cancer | NA | BeFree | Detail | |
0.005 | Carcinoma of lung | These effects may result from the ability of miR-5100 to promote G1/S transition... | BeFree | 25754817 | Detail |
0.005 | Secondary malignant neoplasm of lymph node | As a consequence, the expression of COX-2 and PCNA was found in cancer tissues w... | BeFree | 24992958 | Detail |
0.004 | colon carcinoma | Cyclin-dependent kinase 8 (CDK8), a gene encoding the cyclin-dependent kinase (C... | BeFree | 25305448 | Detail |
0.010 | stomach carcinoma | Knockdown of EGFR reduced cell proliferation and invasion of GC with decreased e... | BeFree | 25394504 | Detail |
0.010 | stomach carcinoma | Functional analysis studies revealed that ectopic expression of miR-133a reduced... | BeFree | 25620172 | Detail |
0.004 | Carcinoma of bladder | RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and mig... | BeFree | 25647262 | Detail |
0.004 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
<0.001 | cervical cancer squamous cell | NA | BeFree | Detail | |
<0.001 | Arnold-Chiari Malformation, Type I | NA | BeFree | Detail | |
<0.001 | Well Differentiated Oligodendroglioma | NA | BeFree | Detail | |
<0.001 | familial retinoblastoma | NA | BeFree | Detail | |
<0.001 | Spots on skin | NA | BeFree | Detail | |
<0.001 | Testicular malignant germ cell tumor | NA | BeFree | Detail | |
<0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Pancreatic Ductal | NA | BeFree | Detail | |
0.002 | ovarian neoplasm | NA | BeFree | Detail | |
<0.001 | Vascular inflammations | NA | BeFree | Detail | |
<0.001 | Ovarian adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Tauopathies | NA | BeFree | Detail | |
<0.001 | Invasive Ductal Breast Carcinoma | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of ovary | Cell growth was inhibited by the overexpression of miR-138, although not by the ... | BeFree,GAD | 25190487 | Detail |
<0.001 | endometrial adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
<0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
0.004 | sarcoma | NA | BeFree | Detail | |
<0.001 | Lymphocytic infiltration | NA | BeFree | Detail | |
<0.001 | basaloid squamous cell carcinoma | NA | BeFree | Detail | |
0.001 | Primary Effusion Lymphoma | NA | BeFree | Detail | |
<0.001 | Salivary duct carcinoma | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | Low Grade Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | ACTH-secreting pituitary adenoma | NA | BeFree | Detail | |
<0.001 | Astrocytoma, low grade | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | autoimmune lymphoproliferative syndrome | Further study indicated that most of the genes in the coexpression network were ... | BeFree | 25299107 | Detail |
<0.001 | B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma | NA | BeFree | Detail | |
<0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Endometrial Endometrioid Adenocarcinoma | Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma. | BeFree | 25315186 | Detail |
<0.001 | Endometrial Endometrioid Adenocarcinoma | Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endo... | BeFree | 26026100 | Detail |
<0.001 | carcinoma of the renal pelvis and ureter | NA | BeFree | Detail | |
<0.001 | Benign melanocytic nevus | NA | BeFree | Detail | |
0.008 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Breast Cancer Model | NA | BeFree | Detail | |
<0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
<0.001 | Mammary Tumorigenesis | NA | BeFree | Detail | |
<0.001 | Cancer Cell Growth | RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and mig... | BeFree | 25647262 | Detail |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.007 | colorectal cancer | NA | BeFree,GAD | Detail | |
<0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Rectal Tumors | NA | BeFree | Detail | |
<0.001 | smoldering myeloma | NA | BeFree | Detail | |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
0.001 | androgen independent prostate cancer | NA | BeFree | Detail | |
<0.001 | Invasive Skin Melanoma | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Primary Focal Segmental Glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
<0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
<0.001 | Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies | NA | BeFree | Detail | |
<0.001 | Familial primary gastric lymphoma | NA | BeFree | Detail | |
<0.001 | lateral meningocele syndrome | NA | BeFree | Detail | |
<0.001 | Inverted Squamous Cell Papilloma | Significantly elevated levels of Ki-67, p27, and PCNA in IP with squamous cell c... | BeFree | 25013792 | Detail |
0.001 | uterine corpus cancer | Overexpression of cyclin B has been shown to affect survival in some malignant t... | BeFree | 25315186 | Detail |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
0.004 | Non-small cell lung carcinoma | Our results indicate that SNPs in the NER genes ERCC1 (Asn118Asn, 15310G>C, 8... | BeFree | 16195237 | Detail |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
<0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
<0.001 | low grade glioma | The protein expression of PCNA and EGFR was significantly higher in high-grade t... | BeFree | 25688509 | Detail |
0.107 | liver carcinoma | Silencing ARPP-19 in HCC cells resulted in decreased protein levels of phospho-(... | BeFree,LHGDN,RGD | 25547487 | Detail |
0.107 | liver carcinoma | Consistent with these results, the expression of SRC-1 was positively correlated... | BeFree,LHGDN,RGD | 26082485 | Detail |
<0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
<0.001 | X-linked infantile spasm syndrome | NA | BeFree | Detail | |
<0.001 | Pilar and trichilemmal cysts | NA | BeFree | Detail | |
0.003 | myelodysplastic syndrome | NA | BeFree,LHGDN | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | PSEUDOHYPOALDOSTERONISM, TYPE IID | Moreover, these animals exhibited renal inflammation, fibrosis, and increased cy... | BeFree | 25250572 | Detail |
<0.001 | Warts | NA | BeFree | Detail | |
0.005 | Infection | NA | LHGDN | Detail | |
0.240 | Ataxia-telangiectasia-like disorder 2 | NA | ORPHANET,UNIPROT | Detail | |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
0.129 | adenocarcinoma | NA | BeFree,CTD_human,LHGDN | Detail | |
0.009 | adenoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Adenovirus Infections | Key messages: Cyclin E promoter activity is high in cancer cells and enhanced by... | BeFree | 25376708 | Detail |
<0.001 | adrenal gland hyperfunction | Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target f... | BeFree | 25942479 | Detail |
0.003 | AIDS Dementia Complex | NA | LHGDN | Detail | |
<0.001 | Alzheimer's disease | We have previously found that cyclin E expression is augmented in cancer cells a... | BeFree | 25376708 | Detail |
<0.001 | Arthritis, Adjuvant-Induced | NA | BeFree | Detail | |
<0.001 | rheumatoid arthritis | RA treatment reduced the expression of several of the investigated genes; the pr... | BeFree | 24509616 | Detail |
<0.001 | asthma | NA | BeFree | Detail | |
0.002 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
<0.001 | Basal Cell Nevus Syndrome | NA | BeFree | Detail | |
0.001 | Beckwith-Wiedemann syndrome | Here we report that p57Kip2, a cyclin-dependent kinase (CDK) inhibitor implicate... | BeFree | 25195859 | Detail |
0.001 | Beckwith-Wiedemann syndrome | Cyclin-dependent kinase (CDK)-inhibitor 1C (CDKN1C) negatively regulates cellula... | BeFree | 25262539 | Detail |
<0.001 | Benign Ovarian Neoplasm | NA | BeFree | Detail | |
0.011 | Malignant neoplasm of urinary bladder | RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and mig... | BeFree,GAD | 25647262 | Detail |
<0.001 | Bladder Neoplasm | NA | BeFree | Detail | |
<0.001 | Blast Phase | NA | BeFree | Detail | |
<0.001 | borderline personality disorder | NA | BeFree | Detail | |
0.123 | Brain Neoplasms | NA | BeFree,CTD_human,GAD | Detail | |
0.003 | Breast Diseases | NA | LHGDN | Detail | |
<0.001 | bronchopulmonary dysplasia | NA | BeFree | Detail | |
<0.001 | Burkitt lymphoma | NA | BeFree | Detail | |
<0.001 | Carcinoid Tumor | NA | BeFree | Detail | |
0.004 | Malignant tumor of colon | Cyclin-dependent kinase 8 (CDK8), a gene encoding the cyclin-dependent kinase (C... | BeFree | 25305448 | Detail |
0.001 | Malignant neoplasm of endometrium | Overexpression of cyclin B has been shown to affect survival in some malignant t... | BeFree | 25315186 | Detail |
<0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | Doxorubicin (DOX), a broad‑spectrum anthra-cyclin, is in wide clinical use for t... | BeFree | 25592304 | Detail |
<0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
0.004 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.003 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
Significantly elevated levels of Ki-67, p27, and PCNA in IP with squamous cell carcinoma transformat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer ... | DisGeNET | Detail |
Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of cyclin B has been shown to affect survival in some malignant tumors, including bre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Glioblastoma development is often associated with alteration in the activity and expression of cell ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
PCNA staining was increased 3- to 3.5-fold, indicating increased insulin-cell proliferation compared... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interacts with cyclin D, is ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Knockout of SRC-1 in mice reduced diethylnitrosamine/CCl4-induced tumor formation in the liver and t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results imply that CXCL16-CXCR6 axis is involved in the regulation of viability and invasion rat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Autoantibodies to proliferating cell nuclear antigen (PCNA) are specifically, if rarely, present in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We observed a significant increase in ΔNp73 expression and ΔNp73:TAp73 ratio, lower expression of cl... | DisGeNET | Detail |
Knockdown of EGFR reduced cell proliferation and invasion of GC with decreased expression of AKT, PC... | DisGeNET | Detail |
Functional analysis studies revealed that ectopic expression of miR-133a reduced cell proliferation ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using A375 (BRAF-mutated) and Hs294t (non BRAF-mutated but highly metastatic) human melanoma cell li... | DisGeNET | Detail |
Cell cycle control is a promising target in the management of melanoma with early data reporting the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inhibitors of cyclin-dependent kinases 9 have been developed as potential anticancer drugs for the t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results imply that CXCL16-CXCR6 axis is involved in the regulation of viability and invasion rat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The XRCC1 Arg194Trp variant affects the proliferating cell nuclear antigen( PCNA) binding region, wh... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of RASSF5 markedly suppressed cell proliferation and invasion, and induced cell apopt... | DisGeNET | Detail |
Inhibition of osteosarcoma cell progression by MacroH2A via the downregulation of cyclin D and cycli... | DisGeNET | Detail |
When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was downregulated in osteos... | DisGeNET | Detail |
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell L... | DisGeNET | Detail |
Cell growth was inhibited by the overexpression of miR-138, although not by the knockout of Limk1. m... | DisGeNET | Detail |
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell L... | DisGeNET | Detail |
P27(Kip1) expression and cleaved caspase-3 are increased, while cyclin E expression is decreased, in... | DisGeNET | Detail |
Our results indicate that the interaction of PCNA and DNA pol-β contributes to neuronal death in PD. | DisGeNET | Detail |
However, susceptibility genes, such as CDKN2BAS (Cyclin Dependend KiNase 2B AntiSense RNA; alias ANR... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MEG3, HOTAIR, MALAT-1 and proliferating cell nuclear antigen (PCNA) were detected in 52 NFPA samples... | DisGeNET | Detail |
Pituitary cyclin E/E2F1 signaling is a previously unappreciated molecular mechanism underlying neuro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results indicated that the downregulation of CFTR in the cystic follicles was accompanied by red... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The data demonstrated that the expression of P21, cyclin D and phosphorylated retinoblastoma was sig... | DisGeNET | Detail |
Cyclin-dependent kinase inhibitors (CDKi) target the retinoblastoma (RB) signaling network, and have... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present study we have mined these two studies for new therapeutic agents for SCLC and identif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of cyclin B has been shown to affect survival in some malignant tumors, including bre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
RA treatment reduced the expression of several of the investigated genes; the proliferating cell nuc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Significantly elevated levels of Ki-67, p27, and PCNA in IP with squamous cell carcinoma transformat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, the present study reveals that the increased expression of OCT4 is correlated with th... | DisGeNET | Detail |
Consistent with this, CST1 mRNA overexpression was correlated closely with malignancy-associated pro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These effects may result from the ability of miR-5100 to promote G1/S transition and downregulate cy... | DisGeNET | Detail |
Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proli... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interacts with cyclin D, is ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
COX-2 inhibitor celecoxib also suppressed the proliferative activities of GAC cells with decreased e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Downregulation of NF-κB, cyclin D1, cyclin E1, matrix metalloproteinases (MMP)-2, MMP-9, and prolife... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer ... | DisGeNET | Detail |
Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, PCNA mRNA levels markedly increased in invasive NFPAs compared to non-invasive ones (P ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Downregulation of NF-κB, cyclin D1, cyclin E1, matrix metalloproteinases (MMP)-2, MMP-9, and prolife... | DisGeNET | Detail |
In conclusion, the present study reveals that the increased expression of OCT4 is correlated with th... | DisGeNET | Detail |
Consistent with this, CST1 mRNA overexpression was correlated closely with malignancy-associated pro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of cyclin B has been shown to affect survival in some malignant tumors, including bre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of cyclin B has been shown to affect survival in some malignant tumors, including bre... | DisGeNET | Detail |
Doxorubicin (DOX), a broad‑spectrum anthra-cyclin, is in wide clinical use for the treatment and pre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of RASSF5 markedly suppressed cell proliferation and invasion, and induced cell apopt... | DisGeNET | Detail |
Inhibition of osteosarcoma cell progression by MacroH2A via the downregulation of cyclin D and cycli... | DisGeNET | Detail |
When HMGN2 expression was enhanced, the expression of cyclin D1 and PCNA was downregulated in osteos... | DisGeNET | Detail |
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell L... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis. | DisGeNET | Detail |
Genetic alteration of cyclin-dependent kinase inhibitors has been associated with carcinogenesis mec... | DisGeNET | Detail |
RV-cyclin presents a novel and ancient mechanism of retrovirus-induced oncogenesis. | DisGeNET | Detail |
This study was performed to screen cyclin D1 (CCND1) and cyclin dependent kinases (CDK4) genes in or... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell L... | DisGeNET | Detail |
NA | DisGeNET | Detail |
These effects may result from the ability of miR-5100 to promote G1/S transition and downregulate cy... | DisGeNET | Detail |
As a consequence, the expression of COX-2 and PCNA was found in cancer tissues with a higher strong ... | DisGeNET | Detail |
Cyclin-dependent kinase 8 (CDK8), a gene encoding the cyclin-dependent kinase (CDK) component of the... | DisGeNET | Detail |
Knockdown of EGFR reduced cell proliferation and invasion of GC with decreased expression of AKT, PC... | DisGeNET | Detail |
Functional analysis studies revealed that ectopic expression of miR-133a reduced cell proliferation ... | DisGeNET | Detail |
RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and migration, along with t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cell growth was inhibited by the overexpression of miR-138, although not by the knockout of Limk1. m... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Further study indicated that most of the genes in the coexpression network were enriched in ECM-rece... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma. | DisGeNET | Detail |
Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and migration, along with t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Significantly elevated levels of Ki-67, p27, and PCNA in IP with squamous cell carcinoma transformat... | DisGeNET | Detail |
Overexpression of cyclin B has been shown to affect survival in some malignant tumors, including bre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results indicate that SNPs in the NER genes ERCC1 (Asn118Asn, 15310G>C, 8902G>T), XPA (-4G... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The protein expression of PCNA and EGFR was significantly higher in high-grade than low-grade glioma... | DisGeNET | Detail |
Silencing ARPP-19 in HCC cells resulted in decreased protein levels of phospho-(Ser) CDKs substrates... | DisGeNET | Detail |
Consistent with these results, the expression of SRC-1 was positively correlated with PCNA expressio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Moreover, these animals exhibited renal inflammation, fibrosis, and increased cyclin E. These result... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Key messages: Cyclin E promoter activity is high in cancer cells and enhanced by adenovirus infectio... | DisGeNET | Detail |
Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease. | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have previously found that cyclin E expression is augmented in cancer cells after adenovirus (Ad)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
RA treatment reduced the expression of several of the investigated genes; the proliferating cell nuc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we report that p57Kip2, a cyclin-dependent kinase (CDK) inhibitor implicated in the development... | DisGeNET | Detail |
Cyclin-dependent kinase (CDK)-inhibitor 1C (CDKN1C) negatively regulates cellular proliferation and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and migration, along with t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cyclin-dependent kinase 8 (CDK8), a gene encoding the cyclin-dependent kinase (CDK) component of the... | DisGeNET | Detail |
Overexpression of cyclin B has been shown to affect survival in some malignant tumors, including bre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Doxorubicin (DOX), a broad‑spectrum anthra-cyclin, is in wide clinical use for the treatment and pre... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386493716 dbSNP
- Genome
- hg19
- Position
- chr20:5,095,599-5,107,272
- Variant Type
- snv
Genome browser